semaglutide and heart failure versus placebo in patients with mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials In patients with heart failure
Description
Originally developed for glycemic control in ...
We recommend starting with one capsule per day, one hour before a meal
The analysis got me thinking a lot about the impact of adherence, which we know has been a challenge with these medications
Clinicians should maintain vigilance, especially in adolescents and individuals self-prescribing for weight loss
Here are the details.
